Immunogenicity and Safety Study of SCB-2023 Vaccine as a Booster in Adults
Clinical trial NCT05926440 · WITHDRAWN
Trial details
- NCT number
- NCT05926440
- Sponsor
- Clover Biopharmaceuticals AUS Pty
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-17
- Primary completion
- 2023-08-17
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.